Platelet-rich plasma (PRP) is a commonly used treatment for tendinopathies such as tennis elbow despite the questionable evidence of its efficacy. A recent Cochrane review suggests that it likely does ...

The U.S. Food and Drug Administration (FDA) on Wednesday (June 18) approved Gilead Sciences, opens new tab lenacapavir, a twice-yearly injection, for preventing HIV infection in adults and adolescents ...

In this article, the reinforcement learning (RL)-based finite-time adaptive optimal resilient control issue is studied for uncertain large-scale nonlinear systems under unknown sensor false data ...

Speaking outside court, police say Chinese national Zhenhao Zou is "one of the most prolific predators we have ever seen".

Gilead Sciences, maker of the drug, announced that a twice-a-year injection of lenacapavir has been approved in the United States for HIV prevention under the brand name Yeztugo.

Gilead Sciences, maker of the drug, announced that a twice-a-year injection of lenacapavir has been approved in the United States for HIV prevention under the brand name Yeztugo, and seen here in ...

SPRINGFIELD, Ill. (WICS) — The Springfield City Council approved a $302,000 resolution for City Water, Light and Power's (CWLP) proposed injection well project with a 6-2 vote on Tuesday. The project ...

The FDA announced today that they've approved a twice-yearly injection for preventing HIV infection in adults and kids. News On 6's Sam Carrico spoke to an HIV specialist about what this means for ...

(CNN) — A drug currently used to treat certain HIV infections has also, on Wednesday, received approval from the US Food and Drug Administration to be used to prevent HIV. Gilead Sciences, maker of ...

A drug currently used to treat certain HIV infections has also, on Wednesday, received approval from the US Food and Drug Administration to be used to prevent HIV.